首页> 美国卫生研究院文献>BMB Reports >Translocator protein (TSPO): the new story of the old protein in neuroinflammation
【2h】

Translocator protein (TSPO): the new story of the old protein in neuroinflammation

机译:转运蛋白(TSPO):神经炎症中旧蛋白的新故事

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Translocator protein (TSPO), also known as peripheral benzodiazepine receptor, is a transmembrane protein located on the outer mitochondria membrane (OMM) and mainly expressed in glial cells in the brain. Because of the close correlation of its expression level with neuropathology and therapeutic efficacies of several TSPO binding ligands under many neurological conditions, TSPO has been regarded as both biomarker and therapeutic target, and the biological functions of TSPO have been a major research focus. However, recent genetic studies with animal and cellular models revealed unexpected results contrary to the anticipated biological importance of TSPO and cast doubt on the action modes of the TSPO-binding drugs. In this review, we summarize recent controversial findings on the discrepancy between pharmacological and genetic studies of TSPO and suggest some future direction to understand this old and mysterious protein.
机译:转运蛋白(TSPO),也称为外周苯并二氮杂receptor受体,是一种位于跨线粒体膜(OMM)上的跨膜蛋白,主要在大脑的神经胶质细胞中表达。由于其表达水平与神经病理学和几种TSPO结合配体在许多神经病学条件下的治疗效果密切相关,因此TSPO被视为生物标志物和治疗靶标,并且TSPO的生物学功能已成为主要研究重点。然而,最近对动物和细胞模型进行的遗传研究显示出与TSPO预期的生物学重要性相反的出乎意料的结果,并对TSPO结合药物的作用方式产生了怀疑。在这篇综述中,我们总结了关于TSPO的药理学和遗传学研究之间的差异的最新有争议的发现,并提出了理解这一古老而神秘的蛋白质的未来方向。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号